-

What are the Key Factors Influencing the Pharma Supply Chain? | SpendEdge’s Latest Blog Explains

LONDON--(BUSINESS WIRE)--SpendEdge, a leading provider of procurement market intelligence solutions, has announced the completion of their latest article on trends driving the pharma industry.

Currently, pharma supply chains are complex, underutilized, and inefficient. They could not cope with the new drugs that are coming down the pipeline. The majority of medicines require enhanced manufacturing and distribution techniques. Hence, companies in the industry need a new approach to the pharma supply chain to address immediate challenges such as the rationalization of larger manufacturing networks.

At SpendEdge, we understand that companies have started revamping their supply chains. And to help them devise effective strategies, we have highlighted key factors impacting the pharma supply chain.

Factors Impacting the Pharma Supply Chain

New drugs and devices

With new bioengineered vaccines and biologics, pharma supply chains will change dramatically. Companies will be forced to develop more complex manufacturing and distribution processes to prevent impurities in the production process. Also, companies will require novel delivery devices for the majority of specialist treatments, thereby, creating the need for more complex devices.

Want to improve pharma supply chain capabilities? Request free platform access to leverage our smart procurement solutions now and 1000+ procurement reports!

Conditional approvals

The launch process for medicines is expected to become more incremental. The approval process for medicines will be graduated due to the introduction of conditional approvals for certain drugs by the US Food and Drug Administration (FDA). Also, regulatory bodies are emphasizing on post-market surveillance and “live licenses” to confirm the efficacy of medicines. To understand compliance requirements in the US pharma market, get in touch with our experts now!

Demand-driven supply chains

Rising clinical advances will offer patients better medicines for acute conditions. This will reduce dependency on hospitals and companies to build demand-driven supply chains and assemble healthcare packages for different patients at ‘super hubs’ before delivering to patients’ homes.

To know more about the factors impacting the pharma supply chain, read the complete article here!

You may also like:

About SpendEdge:

SpendEdge shares your passion for driving sourcing and procurement excellence. We are the preferred procurement market intelligence partner for 120+ Fortune 500 firms and other leading companies across numerous industries. Our strength lies in delivering robust, real-time procurement market intelligence reports and solutions.

Want to gain detailed insights? https://www.spendedge.com/get-more-info

Contacts

SpendEdge
Anirban Choudhury
Marketing Manager
US: +1 630 984 7340
UK: +44 148 459 9299
https://www.spendedge.com/contact-us

SpendEdge


Release Summary
In this blog, we discuss the key factors impacting the pharma supply chain.
Release Versions

Contacts

SpendEdge
Anirban Choudhury
Marketing Manager
US: +1 630 984 7340
UK: +44 148 459 9299
https://www.spendedge.com/contact-us

Social Media Profiles
More News From SpendEdge

Essential Oils Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2021-2025 | SpendEdge

LONDON--(BUSINESS WIRE)--Essential Oils market will register an incremental spend of about USD 5.1 billion, growing at a CAGR of 10.15% during the five-year forecast period....

Emulsifiers Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2021-2025

LONDON--(BUSINESS WIRE)--The Emulsifiers market will register an incremental spend of about USD 3.04 billion, growing at a CAGR of 6.79% during the five-year forecast period....

Empty Capsules Market Procurement Intelligence Report with COVID-19 Impact Analysis | Global Forecasts, 2021-2025

LONDON--(BUSINESS WIRE)--Empty Capsules market will register an incremental spend of about USD 0.81 billion, growing at a CAGR of 6.22% during the five-year forecast period....
Back to Newsroom